Herpes Simplex Virus Treatment Industry - Regional Synopsis
North America Market Statistics
Regionally, the global herpes simplex virus treatment market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. North America industry is predicted to account for largest revenue share by 2037, on the back of high government investment in this sector, along with presence of leading pharmaceutical companies conducting innovative clinical experiments. According to other report of the WHO, per capita healthcare expenditure in North America valued around USD 10,050.279 in the year 2018. Moreover, rising demand for advanced treatment options and growing R&D investment for medical research, are estimated to further boost the market growth in the region.
APAC Market Analysis
The market in the Asia Pacific region is estimated to witness highest CAGR over the forecast period owing to the high prevalence of cancer, and other chronic disease, backed by the growing geriatric population and advancing medical facilities.
